Plastic Surgery Doctors in Wilmington, DE Accepting Medicare

7 Plastic Surgery doctors found. Showing 1 - 7

Dr. John Joseph Danyo Jr., MD Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 4001 Kennett Pike Ste 234, Wilmington, DE 19807 Phone: 302-888-0508    Fax: 302-888-0509

Marcia F Saunders, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Westbrae Ln, Wilmington, DE 19807 Phone: 302-658-7688

Dr. Ian Michael Lonergan, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 Pennsylvania Ave, Wilmington, DE 19806 Phone: 302-656-0214    Fax: 877-284-8933

Susan E. Otero, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 251 Little Falls Dr, Wilmington, DE 19808 Phone: 310-445-5999

Neil A Deleeuw, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 Pennsylvania Ave, Wilmington, DE 19806 Phone: 302-656-0214

Dr. Edward Joseph Caterson, M.D., PH.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200    Fax: 302-651-4945

Mr. John W Gillespie Iii, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2383 Limestone Rd, 2nd Fl, Wilmington, DE 19808 Phone: 302-274-2996    Fax: 302-274-2987

News Archive

Total Wellness ready to meet increased demand for the seasonal flu vaccine

Omaha-based Total Wellness, a leading provider of corporate health and wellness services, encourages employers – both large and small – to follow recommendations made by the Center for Disease Control and Prevention (CDC), which encourages employees to receive flu shots this fall.

Hospira's Nivestim receives Australian TGA approval

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration approval for its biosimilar filgrastim product, Nivestim.

RT after surgery could reduce chances of local DCIS recurrence by 50%

Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) still has a major protective effect against recurrence more than 15 years later, according to the results of an international trial.

Russian Ministry of Health approves Medivir's simeprevir for chronic hepatitis C genotype 1 infection

Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.

Read more Medical News

› Verified 1 days ago